Skip to main content

Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design

Project description

Beating cardiac arrhythmia

An arrhythmia refers to a condition when the heart beats too fast or too slow. Improving the clinical outcome for individuals with inherited arrhythmias – passed down from generation to generation – is the main objective of the EU-funded MOLEC ANTI-ARRHYT project. It will forge new paths for personalised risk stratification, drug design and clinical management. Characterised by diverse clinical manifestations, the project will investigate an important yet unexplored underlying cause – endogenous resilience and trigger factors that interact with mutated cardiac ion channels to alter arrhythmia severity. It will use front-line experimental and computational approaches, as well as cardiac potassium channels for this study.

Call for proposal

ERC-2019-STG
See other projects for this call

Funding Scheme

ERC-STG - Starting Grant

Host institution

LINKOPINGS UNIVERSITET
Address
Campus Valla
581 83 Linkoping
Sweden
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 1 499 998

Beneficiaries (1)

LINKOPINGS UNIVERSITET
Sweden
EU contribution
€ 1 499 998
Address
Campus Valla
581 83 Linkoping
Activity type
Higher or Secondary Education Establishments